Mitoxantrone-d8

Modify Date: 2024-01-10 17:14:57

Mitoxantrone-d8 structure	Common Name	Mitoxantrone-d8
	CAS Number	1189974-82-0	Molecular Weight	452.53000
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₂H₂₀D₈N₄O₆	Melting Point	145 °C
	MSDS	N/A	Flash Point	N/A

Use of Mitoxantrone-d8

Mitoxantrone-d8 (mitozantrone-d8) is the deuterium labeled Mitoxantrone. Mitoxantrone is a topoisomerase II inhibitor and also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM[1][2].

Name	Mitoxantrone-d8
Synonym	More Synonyms

Description	Mitoxantrone-d8 (mitozantrone-d8) is the deuterium labeled Mitoxantrone. Mitoxantrone is a topoisomerase II inhibitor and also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM[1][2].
Related Catalog	Signaling Pathways >> Epigenetics >> PKC Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Topoisomerase Signaling Pathways >> TGF-beta/Smad >> PKC
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Takeuchi N, et al. Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells. J Biochem. 1992 Dec;112(6):762-7. [3]. Bellosillo B, et al. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol. 1998 Jan;100(1):142-6. [4]. Vibet S, et al. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines. Drug Metab Dispos. 2007 May;35(5):822-8. [5]. Fujimoto S, et al. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics. Cancer Chemother Pharmacol. 1982;8(2):157-62.

Melting Point	145 °C
Molecular Formula	C₂₂H₂₀D₈N₄O₆
Molecular Weight	452.53000
Exact Mass	452.25100
PSA	163.18000
LogP	0.78860

Hazard Codes	Xi

1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione

Mitoxantrone-d8

Use of Mitoxantrone-d8

Names

Mitoxantrone-d8 Biological Activity

Chemical & Physical Properties

Safety Information

Synonyms